Stocktoria
Charlie's Holdings, Inc. CHUC
OTC · OOTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2001-12-26
Charlie's Holdings, Inc. financials (annual, from 10-K)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.9M | $7.8M | $16.2M | $26.4M | $21.5M | $16.7M | $22.7M | $20.8M | $3.8M | $2.6M |
| Gross profit | $5.7M | $2.9M | — | — | — | — | — | $718,604 | $771,190 | $321,863 |
| R&D expense | — | — | $169,000 | $804,000 | $24,000 | $3.4M | $1.1M | $0 | — | — |
| Operating income | -$2.2M | -$3.3M | -$2.2M | -$1.8M | $565,000 | -$6.8M | -$5.8M | $7.2M | -$14.4M | -$8.3M |
| Interest expense | — | — | $477,000 | $155,000 | $34,000 | $134,000 | $0 | $813,545 | $158,419 | $39,789 |
| Income tax | $275,000 | $0 | $0 | -$92,000 | $342,000 | $0 | $29,000 | $0 | $0 | $0 |
| Net income | $4.5M | -$4.2M | -$2.1M | -$1.6M | $4.8M | -$7.2M | -$2.1M | $7.2M | -$12.4M | -$5.4M |
| EPS (diluted) | $0.02 | $-0.02 | $-0.01 | $-0.01 | $0.01 | $-0.04 | $0.00 | $0.00 | — | — |
| Operating cash flow | -$6.3M | -$2.0M | -$783,000 | -$1.7M | -$1.3M | -$3.3M | -$2.0M | $7.6M | -$6.4M | -$5.7M |
| Free cash flow | -$6.3M | -$2.0M | -$783,000 | -$1.9M | -$1.5M | -$3.4M | -$2.6M | $7.6M | -$6.4M | -$5.7M |
| Cash & equivalents | — | — | — | — | — | — | — | $43,181 | $76,534 | $224,876 |
| Inventory | $6.7M | $2.1M | $3.8M | $3.7M | $5.0M | $1.6M | $1.5M | $658,000 | $1.2M | $318,912 |
| Total assets | $11.6M | $3.9M | $5.8M | $7.1M | $9.2M | $6.5M | $7.8M | $2.2M | $4.9M | $4.9M |
| Total liabilities | $8.1M | $5.7M | $5.9M | $5.4M | $6.1M | $12.5M | $8.4M | $1.4M | $10.3M | $7.2M |
| Shareholders' equity | $3.4M | -$1.8M | -$107,000 | $1.7M | $3.1M | -$6.0M | -$547,000 | $791,000 | $1.5M | -$2.2M |
Growth · year-over-year · Revenue CAGR 26.2%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +169.4% | -52.2% | -38.5% | +22.9% | +28.8% | -26.6% | +9.1% | +445.1% | +48.5% | -57.9% |
| Net income growth | — | — | — | -133.1% | — | — | -129.8% | — | — | — |
| EPS growth | — | — | — | -200.0% | — | — | — | — | — | — |
| Free cash flow growth | — | — | — | — | — | — | -134.3% | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0001134765 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.